Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants
نویسندگان
چکیده
منابع مشابه
Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.
The goals of tolerance in patients with solid organ transplants are to eliminate the lifelong need for immunosuppressive (IS) drugs and to prevent graft loss due to rejection or drug toxicity. Tolerance with complete withdrawal of IS drugs has been achieved in recipients of HLA-matched and mismatched living donor kidney transplants in 3 medical centers using hematopoietic cell transplants to es...
متن کاملNew Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
In the 30 years since the rabbit antithymocyte globulin (rATG) Thymoglobulin(®) was first licensed, its use in solid organ transplantation and hematology has expanded progressively. Although the evidence base is incomplete, specific roles for rATG in organ transplant recipients using contemporary dosing strategies are now relatively well-identified. The addition of rATG induction to a standard ...
متن کاملEvolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance.
The immunoregulatory properties of hematopoietic stem cells (HSCs) have been recognized for more than 60 years, beginning in 1945, when Owen reported that genetically disparate freemartin cattle sharing a common placenta were red blood cell chimeras. In 1953, Billingham, Brent, and Medawar demonstrated that murine neonatal chimeras prepared by infusion of donor-derived hematopoietic cells exhib...
متن کاملThe use of cyclosporin in organ transplants
Cyclosporin is a metabolite isolated from culture broths of the fungus Tolypocladium inflatum Gams which was shown to be immunosuppressive by Borel et al. in rats, mice and guinea-pigs.1.2 Cyclosporin may directly block the release of interleukin I from activated T helper cells and indirectly block the release of interleukin II from macrophages, thus suppressing both cellular and humoral immuni...
متن کاملTolerance to solid organ transplants through transfer of MHC class II genes.
Donor/recipient MHC class II matching permits survival of experimental allografts without permanent immunosuppression, but is not clinically applicable due to the extensive polymorphism of this locus. As an alternative, we have tested a gene therapy approach in a preclinical animal model to determine whether expression of allogeneic class II transgenes (Tg's) in recipient bone marrow cells woul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2016
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2015-12-685107